Data Highlight Magrolimab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

- Eight Presentations on Yescarta and TecartusAdvance Kite's Cell Therapy Leadership - - New Data Highlight Magrolimab's Potential to Alter the Tumor Microenvironment - Gilead Sciences, Inc. (Nasdaq:

United statesFoster cityCarol ohearFrank neumannJacquie rossBrexucabtagene autoleucelPivekimab sunirineAxicabtagene ciloleucelCressida robsonMeaghan smithDecitabine cedazuridineSanta monicaGlobal head of clinical developmentGilead sciencesGilead sciences incClinical development